Kidney Disease clinical trials

Explore recruiting kidney disease clinical trials.

Recruiting kidney disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Early Sedation with Dexmedetomidine vs. Placebo in Older Ventilated Critically Ill Patients

Netherlands, Ireland, Finland, Germany, Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events

Czechia, Germany, Belgium, Netherlands, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Obinutuzumab induced decreases of PLA2Rab in MN: a pilot study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sefaxersen, an Antisense Inhibitor of Complement Factor B, in Patients with Primary IgA Nephropathy at High Risk of Progression

France, Greece, Czechia, Germany, Italy, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Adult and Pediatric Subjects With APOL1-mediated Proteinuric Kidney Disease

Belgium, France

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized, controlled study to evaluate LNP023 (iptacopan) in patients with active ANCA-associated vasculitis.

Hungary, Denmark, Austria, Netherlands, Spain, Germany +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Kidney Disease trials by city

Kidney Disease in Toronto Kidney Disease in Vancouver Kidney Disease in Montreal Kidney Disease in Calgary Kidney Disease in Edmonton Kidney Disease in Ottawa Kidney Disease in Winnipeg Kidney Disease in Quebec City Kidney Disease in Hamilton Kidney Disease in Kitchener Kidney Disease in London Kidney Disease in Halifax Kidney Disease in New York Kidney Disease in Los Angeles Kidney Disease in Chicago Kidney Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease